A. Delacourte

1.2k total citations
45 papers, 909 citations indexed

About

A. Delacourte is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, A. Delacourte has authored 45 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 13 papers in Molecular Biology and 10 papers in Neurology. Recurrent topics in A. Delacourte's work include Alzheimer's disease research and treatments (26 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Prion Diseases and Protein Misfolding (5 papers). A. Delacourte is often cited by papers focused on Alzheimer's disease research and treatments (26 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Prion Diseases and Protein Misfolding (5 papers). A. Delacourte collaborates with scholars based in France, United States and United Kingdom. A. Delacourte's co-authors include Luc Buée, A. Défossez, Stéphane Flament, Brigitte Hémon, Patrick Vermersch, Florence Pasquier, Didier Leys, M Steinling, Jean‐Pierre Pruvo and A. Wattez and has published in prestigious journals such as The EMBO Journal, FEBS Letters and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

A. Delacourte

45 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Delacourte France 15 631 317 249 219 180 45 909
Jan Six Belgium 10 972 1.5× 556 1.8× 177 0.7× 199 0.9× 306 1.7× 11 1.3k
Daniel Joyner United States 5 578 0.9× 290 0.9× 230 0.9× 187 0.9× 256 1.4× 6 846
Jane Cooper United Kingdom 12 420 0.7× 406 1.3× 140 0.6× 186 0.8× 247 1.4× 17 924
Ajeet Rijal Upadhaya Germany 14 570 0.9× 255 0.8× 100 0.4× 172 0.8× 131 0.7× 16 743
J. K. Blusztajn United States 13 598 0.9× 414 1.3× 68 0.3× 159 0.7× 227 1.3× 17 992
Lakshman Puli Finland 11 422 0.7× 238 0.8× 176 0.7× 202 0.9× 268 1.5× 14 883
Tom Thomas United States 11 632 1.0× 249 0.8× 128 0.5× 345 1.6× 92 0.5× 25 941
Junichi Takamatsu Japan 15 513 0.8× 217 0.7× 151 0.6× 279 1.3× 129 0.7× 25 844
Masakuni Amari Japan 15 503 0.8× 275 0.9× 431 1.7× 207 0.9× 123 0.7× 45 1.0k
Shengjun Chang United States 6 590 0.9× 376 1.2× 64 0.3× 147 0.7× 205 1.1× 8 851

Countries citing papers authored by A. Delacourte

Since Specialization
Citations

This map shows the geographic impact of A. Delacourte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Delacourte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Delacourte more than expected).

Fields of papers citing papers by A. Delacourte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Delacourte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Delacourte. The network helps show where A. Delacourte may publish in the future.

Co-authorship network of co-authors of A. Delacourte

This figure shows the co-authorship network connecting the top 25 collaborators of A. Delacourte. A scholar is included among the top collaborators of A. Delacourte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Delacourte. A. Delacourte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frisoni, Giovanni B. & A. Delacourte. (2009). Neuroimaging outcomes in clinical trials in Alzheimer's disease. The journal of nutrition health & aging. 13(3). 209–212. 17 indexed citations
2.
Abad‐Rodríguez, José, Cristian Galván, Pilar Navarro, et al.. (2003). Raft disorganisation leads to reduced plasmin activity in Alzheimer's disease brains. The EMBO Journal. 4. 1190–1196. 1 indexed citations
3.
Delacourte, A.. (2001). The Molecular Parameters of Tau Pathology. Advances in experimental medicine and biology. 487. 5–19. 10 indexed citations
4.
Delacourte, A. & Luc Buée. (2000). Tau pathology: a marker of neurodegenerative disorders. Current Opinion in Neurology. 13(4). 371–376. 103 indexed citations
5.
Pasquier, Florence & A. Delacourte. (1998). Non‐Alzheimer degenerative dementias. Current Opinion in Neurology. 11(5). 417–427. 35 indexed citations
6.
Delacourte, A. & Luc Buée. (1997). Normal and Pathological Tau Proteins as Factors for Microtubule Assembly. International review of cytology. 171. 167–224. 96 indexed citations
7.
Défossez, A., et al.. (1995). Immunogold labelling of paired helical filaments and amyloid fibrils by specific monoclonal and polyclonal antibodies. Acta Neuropathologica. 90(5). 441–447. 11 indexed citations
8.
Sergeant, Nicolas, Thierry Bussière, Patrick Vermersch, Julien Lejeune, & A. Delacourte. (1995). Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins. Neuroreport. 6(16). 2217–2220. 36 indexed citations
9.
Vermersch, Patrick, P. Sautière, M. Goudemand, & A. Delacourte. (1993). General cortical involvement in a late-onset case of Alzheimer disease. Molecular and Chemical Neuropathology. 18(3). 213–224. 2 indexed citations
10.
Hof, Patrick R., A. Delacourte, Luc Buée, et al.. (1992). Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism. Neuroscience Letters. 139(1). 10–14. 27 indexed citations
11.
Ceballos, I., Annie Nicole, Pascale Briand, et al.. (1991). Expression of Human Cu-Zn Superoxide Dismutase Gene in Transgenic Mice: Model for Gene Dosage Effect in Down Syndrome. Free Radical Research Communications. 13(1). 581–589. 32 indexed citations
12.
Ceballos, I., F. Javoy‐Agid, A. Delacourte, et al.. (1991). Neuronal Localization of Copper-Zinc Superoxide Dismutase Protein and mRNA within the Human Hippocampus from Control and Alzheimer'S Disease Brains. Free Radical Research Communications. 13(1). 571–580. 32 indexed citations
13.
Leys, Didier, Jean‐Pierre Pruvo, Patrick Vermersch, et al.. (1991). Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?. Journal of Neurology Neurosurgery & Psychiatry. 54(1). 46–50. 133 indexed citations
14.
Rosemblatt, Mario, Arlette Fellous, J C Mazié, A. Delacourte, & A. Défossez. (1989). Alzheimer's disease: Microtubule‐associated proteins 2 (MAP 2) are not components of paired helical filaments. FEBS Letters. 252(1-2). 91–94. 11 indexed citations
15.
Flament, Stéphane, A. Delacourte, Brigitte Hémon, & A. Défossez. (1989). Characterization of two pathological Tau protein variants in Alzheimer brain cortices. Journal of the Neurological Sciences. 92(2-3). 133–141. 88 indexed citations
16.
Défossez, A., et al.. (1989). [Alzheimer's disease: immunohistochemical characterization of cerebral amyloid deposits].. PubMed. 308(16). 437–44. 2 indexed citations
17.
Peers, Marie-Claire, et al.. (1988). Cortical angiopathy in Alzheimer's disease: The formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the pathological vessels. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 414(1). 15–20. 18 indexed citations
18.
Delacourte, A. & A. Défossez. (1987). Alzheimer??s disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. Alzheimer Disease & Associated Disorders. 1(3). 204–204. 9 indexed citations
19.
Lesieur, Daniel, et al.. (1986). Chemical and pharmacological studies of 2-(amino-methyl)acrylophenones.. PubMed. 36(1). 20–4. 2 indexed citations
20.
Delacourte, A., et al.. (1984). Antimicrotubular effects of ethacrynic acid.. PubMed. 6(11). 675–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026